Loading page…
Healthcare
Summit Therapeutics Inc. attains an AlphaScore of 63/100 in the Healthcare sector, carrying a watch signal and a market capitalization of $14.03 billion. Essential metrics include a very low debt-to-equity ratio of 0.03 and a negative forward P/E of -15.42. A distinct strength is its minimal debt burden, while a major risk is its steep negative return on equity of -163.86%. Evidence is limited to the provided snapshot date of 2026-10-11.
Written 11/10/2026, 00:43:07 UTC · Snapshot 11/10/2026